(Q48974990)

17 February 2018

title

Two subsets of dendritic cells are present in human cerebrospinal fluid. (English)

1 reference

17 February 2018

0 references

1 reference

Pashenkov M

1

1 reference

17 February 2018

Huang YM

2

1 reference

17 February 2018

Kostulas V

3

1 reference

17 February 2018

Haglund M

4

1 reference

17 February 2018

Söderström M

5

1 reference

17 February 2018

Link H

6

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 March 2001

1 reference

17 February 2018

published in

Brain

1 reference

17 February 2018

volume

124

1 reference

17 February 2018

issue

Pt 3

1 reference

17 February 2018

page(s)

480-492

1 reference

17 February 2018

Dendritic cells and the control of immunity

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

Mechanisms of immune injury in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

Viral induction of low frequency interferon-alpha producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

Antigen presentation function of brain-derived dendriform cells depends on astrocyte help.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

Dendritic cells in experimental allergic encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

Human peripheral blood contains two distinct lineages of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F124.3.480

21 January 2018

Identifiers

DOI

10.1093/BRAIN/124.3.480

1 reference

17 February 2018

1 reference

17 February 2018